INTRODUCTION {#S1}
============

Macroautophagy (hereafter autophagy) is an evolutionarily conserved intracellular degradation process that plays a vital role in the maintenance of cellular and tissue homeostasis ([@R22]). Dysregulation of autophagy has been implicated in the pathogenesis of various human diseases, including cancer, neurodegenerative disease, and vascular disease ([@R1]). Moreover, at the cellular level, autophagosomal membranes have been reported to function as signaling platforms for cell death and survival, including apoptosis, necroptosis, and mitogen-activated protein (MAP)-kinase pathways ([@R6]; [@R20]; [@R40]). Thus, understanding the molecular mechanism of autophagosome biogenesis is pivotal for the development of future autophagy-targeting therapeutics.

The process of autophagy begins with the formation of the phagophore, which undergoes membrane expansion and eventually seals to form a double-membrane vesicle, known as the autophagosome ([@R23]). The autophagosome is then fused with endosomes and lysosomes to deliver the sequestered materials for hydrolytic degradation and nutrient recycling. Although the molecular mechanism of autophagosome biogenesis remains far from clear, yeast genetic screens have identified over 30 autophagy-related (ATG) genes that are important for autophagy ([@R14]; [@R24]). Several upstream ATG proteins, including components of the class III phosphatidylinositol 3-kinase complex, translocate to the mitochondria-associated endoplasmic reticulum (ER) membrane (MAM) for autophagosome formation ([@R9]). Among these ATG proteins, the Atg8/LC3 family of proteins is one of the most studied molecules involved in autophagosome formation. During autophagy, cytosolic LC3-I is conjugated to the lipid phosphatidylethanolamine (PE) to generate LC3-II on the phagophore. The LC3-PE conjugation occurs during phagophore expansion and serves to recruit ubiquitinated cargo through direct interaction with cargo adaptors, such as p62/sequestosome-1. Upon phagophore closure, LC3-II on the outer autophagosomal membrane (OAM) is delipidated and recycled to the cytosol prior to lysosomal fusion, while LC3-II on the inner autophagosomal membrane (IAM) is degraded upon autophagosome-lysosome fusion ([@R12]; [@R21]; [@R41]). Therefore, LC3-II serves as a widely used marker for autophagy ([@R15]).

Although the lipidation of LC3 is associated with phagophore expansion, the mechanism and membrane source for such process remains unknown. Atg9 is the sole transmembrane ATG protein that is required for autophagosome formation ([@R45]). Although Atg9 basally resides in the trans-Golgi network (TGN) and recycling endosomes known as the Atg9 reservoir, vesicles containing Atg9 bud off from the reservoir in response to autophagic stimuli and traffic to the autophagosome formation site ([@R27]; [@R35]; [@R36]; [@R48]). Here, Atg9 only transiently associates with autophagosomal membranes and is rapidly recycled back to the reservoir for reuse ([@R27]; [@R45]). As Atg9 shuttling between the reservoir and phagophore is important for controlling the number and size of autophagosomes ([@R10]; [@R48]), Atg9 (legend continued on next page) vesicles are proposed to deliver membrane and other components for phagophore expansion.

In yeast, Atg2 interacts with Atg9 to promote autophagy and regulate Atg9 retrieval from the pre-autophagosomal structure (PAS) ([@R3]; [@R5]). Atg2 is one of the least understood ATG proteins required for autophagy ([@R5]; [@R34]; [@R44]). Previous studies in yeast have shown that Atg2 can be recruited to PAS through the interaction with the phosphatidylinositol 3-phosphate (PI3P)-binding protein Atg18 ([@R26]; [@R33]). In mammalian cells, two Atg2 orthologs (Atg2A/B) and four Atg18 orthologs (WIPI1--4) have been identified ([@R29]; [@R44]). Although Atg2A and Atg2B are functionally redundant to promote autophagic degradation ([@R44]), WIPI proteins appear to be functionally non-redundant ([@R29]). Among WIPIs, WIPI4 exhibits the strongest physical interaction with mammalian Atg2 and has been reported to be involved in omegasome maturation and autophagosome formation ([@R19]; [@R50]). Although the physiological significance of mammalian Atg2-WIPI4 interaction remains unknown, the loss of Atg2 accumulates cytoplasmic punctate structures containing Atg9/ Atg9A, Atg1/ULK1, Atg14, and Atg16/Atg16L1 in both yeast and human cells([@R40]; [@R44]), suggesting the importance of Atg2 proteins in autophagosome biogenesis.

Here, we demonstrate that the loss of mammalian Atg2A/B significantly impairs autophagy at the phagophore expansion step. During autophagy, Atg2A translocates to the autophagosome formation site at the ER-mitochondria contact site by a C-terminal MAM localization domain (MLD). Although inhibition of Atg2A recruitment to the MAM impairs phagophore expansion and autophagic flux, the MAM targeting of Atg2A occurs independent of its binding to WIPI4 but requires the TOM70-TOM40 complex. Furthermore, we demonstrate that Atg2A directly interacts with Atg9A at the MAM to promote phagophore growth. These results implicate mammalian Atg2A as a critical regulator of Atg9A vesicle delivery and phagophore expansion during autophagosome biogenesis at the MAM.

RESULTS {#S2}
=======

Atg2 Is Required for Autophagosomal Membrane Expansion {#S3}
------------------------------------------------------

Mammalian Atg2A/B proteins are functionally redundant and have been reported to be indispensable for basal and starvation-induced autophagic flux in THP-1 and HeLa cells ([@R40]; [@R44]). Consistently, we found that the loss of Atg2A/B impaired lysosomal turnover of LC3-II and p62 in U-2 OS cells under both basal and starved conditions ([Figures S1A](#SD1){ref-type="supplementary-material"} and [S1B](#SD1){ref-type="supplementary-material"}). To clarify the role of Atg2A/B in autophagosome biogenesis, we next took the advantage of the HaloTagLC3 (HT-LC3) autophagosome completion assay. Briefly, this assay is able to distinguish expanding phagophores from nascent autophagosomes and mature autophagosomes or autolysosomes by sequentially labeling cytosol-accessible and autophagosome-sequestered HT-LC3 by using fluorescently tagged membrane-impermeable (MIL) and membrane-permeable (MPL) HaloTag ligands, respectively ([@R37]). As expected, phagophores (MIL^+^MPL^−^), autophagosomes (MIL^+^MPL^+^), and mature autophagic structures (MILMPL^+^) appeared in the cytoplasmic region of starved wild-type (WT) cells ([Figures 1A](#F1){ref-type="fig"} a--c). Interestingly, all three autophagic structures (MIL^+^MPL^−^, MIL^+^MPL^+^, and MIL^−^MPL^+^ HT-LC3 foci) were also detected in Atg2A/B double knockout (CrAtg2A/B) cells ([Figure 1A](#F1){ref-type="fig"}, d--j). Moreover, the addition of the lysosomal V-ATPase inhibitor Bafilomycin A1 (Baf-A1) slightly but significantly increased MPL signals in CrAtg2A/B cells ([Figure 1C](#F1){ref-type="fig"}), indicating that autophagosomes still can form and mature into autolysosomes in the absence of Atg2A/B. Strikingly, however, we found that the MIL/MPL ratio in the presence of Baf-A1 in CrAtg2A/B cells was significantly higher than that in WT cells to indicate the accumulation of phagophores and/or autophagosomes ([Figure 1D](#F1){ref-type="fig"}). Moreover, MIL signals were significantly increased in CrAtg2A/B cells even under non-starved conditions ([Figures 1B](#F1){ref-type="fig"}), suggesting that Atg2A/B loss delays autophagosome completion under both basal and induced conditions.

Notably, the sizes of HT-LC3 puncta in CrAtg2A/B U-2 OS cells were significantly smaller than those in WT cells ([Figure 1E](#F1){ref-type="fig"}). To verify this phenotype, we performed transmission electron microscopy (TEM). Consistently, although autophagosomeand autolysosome-like structures were observed in both WT and CrAtg2A/B cells ([Figure 1F](#F1){ref-type="fig"}), these autophagic structures were significantly smaller in Atg2A/B-deficient cells ([Figure 1G](#F1){ref-type="fig"}). Taken together, these results indicate that mammalian Atg2A/B functions at the membrane expansion step during autophagosome biogenesis.

It has recently been reported that Atg2A/B deficiency in HeLa cells fails to form typical phagophores and autophagosomes and results in the accumulation of LC3 signals on small, single-membrane vesicle-like structures ([@R38]). We, thus, next performed correlative light and electron microscopy (CLEM) and confirmed that HT-LC3-positive foci in CrAtg2A/B U-2 OS cells indeed represented autophagosome- and autolysosome-like structures ([Figure 1H](#F1){ref-type="fig"}). To determine if the discrepancy is due to the difference in cell types, we generated Atg2A/B-deficient HeLa and HEK293T cells ([Figures S1C](#SD1){ref-type="supplementary-material"} and [S1G](#SD1){ref-type="supplementary-material"}) and analyzed autophagic structures by the HT-LC3 assay and electron microscopy. Consistent with the phenotype observed in U-2 OS cells, small autophagic structures were detected in Atg2A/B-deficient HEK293T and HeLa cells ([Figures S2C](#SD1){ref-type="supplementary-material"}--[S2I](#SD1){ref-type="supplementary-material"}), further supporting the role of mammalian Atg2A/B in phagophore expansion rather than formation.

Atg2A Localizes to ER-Mitochondria Contact Sites {#S4}
------------------------------------------------

To understand the mechanism behind the regulation of phagophore expansion by Atg2, we first determined the precise intracellular location of Atg2 by immunoelectron microscopy by using CrAtg2A/B cells stably expressing single guide RNA (sgRNA)-resistant EGFP-Atg2A. Interestingly, upon nutrient starvation, EGFP-Atg2A signals were detected at ER-mitochondria contact sites, also known as the MAM ([Figure 2A](#F2){ref-type="fig"}). The localization of Atg2A was further determined by confocal microscopy. Consistent with a previous report ([@R44]), EGFP-Atg2A signals were detected throughout the cytoplasmic region as well as in small foci structures under fed conditions ([Figure 2B](#F2){ref-type="fig"}). The fluorescence intensity as well as the number of EGFPAtg2A puncta was significantly increased by starvation ([Figures 2B](#F2){ref-type="fig"}--[2D](#F2){ref-type="fig"}), suggesting the translocation of Atg2A during autophagy. Notably, although nearly all Atg2A puncta were found to be associated with the ER regardless of the nutrient status, a portion of the ER-associated Atg2A signals was also positive for a mitochondrial marker under fed conditiosn ([Figures 2B](#F2){ref-type="fig"} and [2E](#F2){ref-type="fig"}). However, the percentage of Atg2A puncta associated with both ER and mitochondrial markers was significantly increased by starvation ([Figures 2B](#F2){ref-type="fig"} and [2E](#F2){ref-type="fig"}), indicating the accumulation of Atg2A at MAM during autophagy.

Most recently, the membrane-tethering function of Atg2 has been demonstrated *in vitro* using liposomes ([@R25]; [@R28]; [@R43]). Because Atg2A translocates to the MAM during starvation, we next examined if Atg2A/B is important for the formation of ER-mitochondrial contact sites. Electron microscopy showed that the number of MAM in CrAtg2A/B cells was comparable to that in WT cells ([Figures S2A](#SD1){ref-type="supplementary-material"} and [S2B](#SD1){ref-type="supplementary-material"}), indicating that the reduction of autophagosomal membrane size by Atg2A/B depletion is not due to the impairment of MAM formation.

Atg2A-WIPI4 Interaction Is Dispensable for Atg2A Function in Phagophore Expansion {#S5}
---------------------------------------------------------------------------------

It has been reported that knock down of Atg2A/B accumulates GFP-WIPI1-positive LC3 foci ([@R44]). Consistently, we observed an accumulation of the PI3P marker mRFP-FYVE on GFP-ULK1-positive early autophagic structures in CrAtg2A/B cells in a manner that is dependent on the activation of the PI3-kinase ([Figures S2C](#SD1){ref-type="supplementary-material"}--[S2E](#SD1){ref-type="supplementary-material"}). Because the PI3Peffector Atg18 is required for the PAS recruitment of Atg2 in yeast ([@R26]), we next examined if WIPI4, a mammalian Atg18 ortholog, is crucial for Atg2A MAM localization and the function of Atg2A in phagophore expansion. Instead of WIPI4 knockout, which will disrupt multiple cellular functions of WIPI4, we used an Atg2A(YFS-AAA) mutant that abolishes Atg2A-WIPI4 interaction ([Figures S3A](#SD1){ref-type="supplementary-material"} and [S3B](#SD1){ref-type="supplementary-material"}), as previously reported ([@R50]). To our surprise, the mutations in the YFS motif did not block the starvation-induced colocalization of EGFP-Atg2A with dsRed-ER and TOM20 ([Figure S3C](#SD1){ref-type="supplementary-material"}). Moreover, similar to EGFP-Atg2A(WT), EGFP-Atg2A(YFS-AAA) rescued the defects in phagophore expansion and autophagic degradation ([Figures S3D](#SD1){ref-type="supplementary-material"}--[S3G](#SD1){ref-type="supplementary-material"}) in CrAtg2A/B cells. Collectively, these results indicate that the Atg2A-WIPI4 interaction is dispensable for Atg2A translocation to the MAM and the phagophore expansion function of Atg2A.

TOM40 Is an Interacting Partner of Atg2A That Binds to the MLD {#S6}
--------------------------------------------------------------

To determine the minimal region of Atg2A that is required for MAM localization, we next generated a series of Atg2 deletion mutants ([Figure S4A](#SD1){ref-type="supplementary-material"}). We found that a 45-amino acid sequence near the C-terminal end of Atg2A (amino acid 1776--1820) and located within the previously characterized autophagosome and lipid droplet localization region ([@R44]) is sufficient for Atg2A localization to ER-mitochondria contacting sites and, thus, named this region the MLD. Notably, expression of EGFP-Atg2A(1776--1820) (EGFP-MLD) in CrAtg2A/B cells results in MAM localization regardless of nutrient status ([Figures S4B](#SD1){ref-type="supplementary-material"} and [S4C](#SD1){ref-type="supplementary-material"}).

To understand the mechanism underlying the MAM localization of Atg2A, we next took a proteomic approach to identify proteins that associate with the MLD. As Atg2A was previously suggested to only transiently associate with LC3-positive foci ([@R44]), we took the advantage of photo-amino acid UV-crosslinking coupled with affinity purification and proteomics. To minimize the contamination of non-labeled bait proteins and the induction of apoptosis that is observed upon prolonged overexpression of EGFP-MLD ([Figures S4D](#SD1){ref-type="supplementary-material"} and [S4E](#SD1){ref-type="supplementary-material"}), we generated doxycycline-inducible EGFP-empty or EGFP-MLD-expressing CrAtg2A/B cells. The resultant cells were incubated with doxycycline together with photo-leucine and photo-methionine followed by UV-crosslinking, GFPTrap, and mass spectrometry. We recovered a total of 750 preys, and by employing EGFP-empty as a normalization control and a 5-fold increase threshold, 75 potential MLD interacting partners were identified and categorized according to their subcellular localization ([Table S1](#SD1){ref-type="supplementary-material"}). Consistent with the MAM localization of the MLD, over 55% of the potential interacting partners are either mitochondria- or ER-related proteins ([Table S1](#SD1){ref-type="supplementary-material"}), and these were selected for further analyses.

After validation by co-immunoprecipitation in the absence of photo-amino acid labeling and UV photo-crosslinking, we identified TOM40, the central component of the translocase of the outer mitochondrial membrane (TOM) complex ([@R2]), as a MLD-binding protein ([Figures 3A](#F3){ref-type="fig"} and [3B](#F3){ref-type="fig"}). The interaction of TOM40 with full-length Atg2A was confirmed by co-immunoprecipitation using anti-TOM40 antibodies or ectopic expression of EGFP-Atg2A followed by GFP-Trap ([Figures S5A](#SD1){ref-type="supplementary-material"} and [3C](#F3){ref-type="fig"}). To confirm that MLD mediates the interaction between full-length Atg2A and TOM40, we generated an EGFP-Atg2A mutant lacking the MLD ([Figure 3A](#F3){ref-type="fig"}) and examined its interaction with TOM40. As expected, TOM40 interaction was abolished in the absence of MLD ([Figure 3D](#F3){ref-type="fig"}), indicating that Atg2A interacts with TOM40 through the MLD. Importantly, the interaction of Atg2A with TOM40 was enhanced by starvation ([Figures S4A](#SD1){ref-type="supplementary-material"} and [S4B](#SD1){ref-type="supplementary-material"}), suggesting a role of TOM40 in the MAM translocation of Atg2A during autophagy. In contrast, the depletion of upstream ATGs including Atg13 and Atg9A had little effect on the interaction of Atg2A with TOM40 ([Figures S5C](#SD1){ref-type="supplementary-material"} and [S5D](#SD1){ref-type="supplementary-material"}). Collectively, these results identify TOM40 as an interacting partner of Atg2A that binds by its N-terminal MLD.

MLD Harbors Two Putative α Helices That Are Essential for TOM40 Interaction {#S7}
---------------------------------------------------------------------------

To determine the residues of the MLD that are responsible for binding to TOM40, we first aligned the human Atg2A MLD protein sequence with its orthologs. We found that the MLD region and especially several positively charged and hydrophobic residues within this domain are highly conserved among all higher eukaryotes analyzed ([Figure S6A](#SD1){ref-type="supplementary-material"}). We next predicted the secondary and tertiary structure of the human MLD of Atg2A ([Figures S6B](#SD1){ref-type="supplementary-material"} and [S6C](#SD1){ref-type="supplementary-material"}) ([@R46], [@R47]). We found that the 45 amino acids of MLD comprise two α helices that are linked by a short coil ([Figure S6C](#SD1){ref-type="supplementary-material"}). Notably, three highly conserved arginine residues in the N-terminal helix of MLD are oriented on the same side ([Figures 3E](#F3){ref-type="fig"}, [3F](#F3){ref-type="fig"}, and [S6C](#SD1){ref-type="supplementary-material"}), suggesting that these residues may mediate membrane binding ([@R17]; [@R31]). Indeed, we observed that the arginine substitution to alanine ([Figure 3F](#F3){ref-type="fig"}) reduced the foci formation of the MLD ([Figure S6D](#SD1){ref-type="supplementary-material"}). We next determined if the arginine residues are also important for the interaction with TOM40. We found that the MLD and TOM40 interaction was greatly suppressed by the arginine to alanine mutations ([Figure 3G](#F3){ref-type="fig"}), suggesting that the arginine residues on the N-terminal helix of MLD are important not only for membrane recognition but also for the interaction of Atg2A with TOM40.

Photo-leucine and photo-methionine are used for the photoamino acid UV-crosslinking assay because protein-protein interactions frequently require the adaptation of hydrophobic residues into hydrophobic pockets of its interacting partner, such as p21-PCNA and BH3-mediated interactions of Bcl-2 family proteins ([@R7]; [@R32]). To determine if the conserved hydrophobic leucine residues on the C-terminal helix of MLD ([Figure S6A](#SD1){ref-type="supplementary-material"}) are required for interaction with TOM40, we generated a MLD mutant harboring leucine to alanine mutations ([Figures 3E](#F3){ref-type="fig"} and [3F](#F3){ref-type="fig"}). Notably, both foci formation ([Figure S6D](#SD1){ref-type="supplementary-material"}) and TOM40 interaction ([Figure 3G](#F3){ref-type="fig"}) were abolished by the leucine to alanine substitutions in the MLD. To confirm the importance of both helical regions of the MLD in the interaction of Atg2A with TOM40, we generated a full-length Atg2A mutant harboring both arginine and leucine to alanine substitutions in the MLD. Consistently, mutation of the conserved residues abolished the interaction of Atg2A with TOM40 ([Figure 3H](#F3){ref-type="fig"}). Notably, Atg2A(L/R-A) maintains its interaction with WIPI4, whereas the WIPI4 interaction-defective Atg2A(YFS-AAA) mutant interacts with TOM40, indicating that the WIPI4 and TOM40 interactions of Atg2A are achieved by two independent domains ([Figure S6E](#SD1){ref-type="supplementary-material"}). Taken together, these data indicate that the MLD of Atg2A harbors two putative α helices that are essential for TOM40 interaction.

The MAM Localization of Atg2A Is Required for Phagophore Expansion and Autophagic Flux {#S8}
--------------------------------------------------------------------------------------

To investigate whether TOM40 interaction of Atg2A is required for its MAM localization, we first analyzed the intracellular localization of the TOM40 interaction-defective Atg2A(MLD) and Atg2A(L/R-A) mutants. We found that neither EGFPAtg2A(ΔDMLD) nor EGFP-Atg2A(L/R-A) formed puncta or localized to MAM in response to nutrient starvation ([Figures 4A](#F4){ref-type="fig"} and [4B](#F4){ref-type="fig"}), suggesting the importance of the Atg2A-TOM40 interaction in the membrane localization of Atg2A. We next investigated whether the MAM localization of Atg2A is crucial for the expansion of phagophores. In contrast to EGFP-Atg2A(WT), neither EGFP-Atg2A(L/R-A) nor EGFPAtg2A(ΔMLD) rescued the phagophore expansion defect in Atg2A/B-deficient cells ([Figures 4C](#F4){ref-type="fig"} and [4D](#F4){ref-type="fig"}), indicating that MAM localization is a prerequisite for Atg2A to exert its biological function for proper membrane expansion. Furthermore, only EGFP-Atg2A(WT), but not EGFP-Atg2A(L/R-A) nor EGFP-Atg2A(ΔMLD), restored the impaired autophagic flux in CrAtg2A/B cells ([Figures 4E](#F4){ref-type="fig"}--[4J](#F4){ref-type="fig"}). Taken together, these data indicate that Atg2A exerts pro-autophagic function at the ER-mitochondria contacting sites by promoting phagophore expansion for efficient autophagic degradation.

TOM70 Mediates the Atg2A-TOM40 Interaction for Phagophore Expansion {#S9}
-------------------------------------------------------------------

Several additional TOM components, including TOM70, were detected in our proteomics analysis but failed to reach the five-fold enrichment threshold ([Figure 5A](#F5){ref-type="fig"}). TOM70 and TOM20 are two of the major TOM receptors that transiently associate with the core TOM complex to deliver targeted proteins to TOM40 ([@R30]). Interestingly, a recent study has shown that TOM70, but not TOM20, clusters at MAM to recruit inositol trisphosphate receptor calcium transfer ([@R4]). To determine if the TOM70-dependent delivery process is required for the Atg2A-TOM40 complex formation, TOM70-deficient U-2 OS cells were generated ([Figure 5B](#F5){ref-type="fig"}) and subjected to co-immunoprecipitation analysis. Our data showed that the interaction of Atg2A with TOM40 was impaired by the loss of TOM70 ([Figure 5C](#F5){ref-type="fig"}), suggesting a role of the TOM70 pathway in the recruitment of Atg2A to MAM during autophagy. To examine the importance of TOM70-dependent recruitment of Atg2A in phagophore expansion, we used the rapamycininduced FKBP (FK506-binding protein)/FRB (FKBP-rapamycin binding domain) dimerization system ([@R11]). To artificially induce the recruitment of Atg2A to MAM and the outer mitochondrial membrane (OMM) or the OMM alone, FRB-GFP-Atg2A(ΔMLD) was co-transduced to CrAtg2A/B cells with TOM70-mRFP-FKBP or TOM20-mRFP-FKBP, respectively. Rapamycin-induced dimerization of FRB-GFP-Atg2A (ΔMLD) and TOM70-mRFP-FKBP, but not TOM20-mRFPFKBP, restored the size of LC3 puncta in CrAtg2A/B cells ([Figures 5D](#F5){ref-type="fig"} and [5E](#F5){ref-type="fig"}), indicating that TOM70-dependent recruitment of Atg2A to MAM is sufficient to induce phagophore growth upon the induction of autophagy. Notably, however, dimerization of FRB-GFP-Atg2A(ΔMLD) and TOM70-mRFP-FKBP occasionally generated abnormally enlarged LC3-positive structures ([Figures 5E](#F5){ref-type="fig"}), and autophagic flux remained impaired in these cells ([Figure 5F](#F5){ref-type="fig"}). These observations suggest that the dissociation of Atg2A from MAM may be required for functional autolysosome formation.

Atg2A Interacts with Atg9A and Promotes Atg9A Vesicle Delivery for Phagophore Expansion {#S10}
---------------------------------------------------------------------------------------

In yeast, Atg2 has been shown to interact with Atg9 to promote autophagy ([@R5]). Consistently, we observed the interaction between Atg2A and Atg9A in mammalian cells ([Figures 6A](#F6){ref-type="fig"} and [S7B](#SD1){ref-type="supplementary-material"}). Because Atg9 vesicles have been suggested to be a membrane source for phagophore growth ([@R45]), we next examined whether mammalian Atg9A is required for proper phagophore expansion. Similar to the loss of Atg2A/B, autophagic flux is impaired and LC3B puncta diameter is significantly reduced in Atg9A-deficient cells ([Figures 6B](#F6){ref-type="fig"}--[6D](#F6){ref-type="fig"}), supporting the importance of Atg9 vesicles in phagophore expansion. We next determined if mammalian Atg2 proteins are involved in Atg9A trafficking during autophagy. Consistent with previous studies ([@R27]; [@R35]), Atg9A signals in starved WT cells were dispersed throughout the cytoplasmic region with only a small portion of the signals colocalizing with LC3 ([Figures 6E](#F6){ref-type="fig"} and [6F](#F6){ref-type="fig"}). In contrast, the loss of Atg2A/B resulted in the accumulation of Atg9A signals on LC3-positive structures ([Figure 6E](#F6){ref-type="fig"}). Using CLEM, we confirmed that the LC3 and Atg9A-positive structures in CrAtg2A/B cells represent autophagic structures ([Figure 6G](#F6){ref-type="fig"}). Interestingly, the autophagic structures in CrAtg2A/B cells were surrounded by 30- to 50-nm Atg9A-GFP-positive vesicles ([Figure 6G](#F6){ref-type="fig"}). Collectively, these results suggest that mammalian Atg2 proteins are dispensable for the anterograde trafficking of Atg9A but may mediate Atg9A vesicle delivery for phagophore expansion.

To better understand the function of mammalian Atg2 proteins at MAM, we next examined if the Atg2-Atg9 interaction is crucial for phagophore expansion and autophagic degradation. Using a series of deletion mutants ([Figure S7A](#SD1){ref-type="supplementary-material"}), we identified that amino acids 237--431 in the N terminus of Atg2A are essential for the interaction of Atg2A with Atg9A ([Figures 7A](#F7){ref-type="fig"}, [7B](#F7){ref-type="fig"}, and [S7B](#SD1){ref-type="supplementary-material"}). As both EGFP-Atg2A and EGFP-Atg2A(Δ237--431) harbor intact MLD, similar TOM40 interactions were detected ([Figure S7B](#SD1){ref-type="supplementary-material"}), suggesting that the Atg2A-Atg9A interaction is achieved independently from the MLD-mediated TOM40 interaction. Consistently, the starvation-induced MAM localization of EGFP-Atg2A(Δ237--431) remains unaffected ([Figure S7C](#SD1){ref-type="supplementary-material"}). Taken together, these data indicate that EGFP-Atg2A(Δ237--431) localizes to MAM through interaction with TOM40 in response to autophagic stimuli; however, its interaction with Atg9A is abolished.

We next examined whether the Atg2A-Atg9A interaction at the MAM is required for the phagophore expansion functions of Atg2A. Although both Atg2A(WT) and Atg2A(Δ237--431) localize to MAM upon nutrient starvation ([Figure S7C](#SD1){ref-type="supplementary-material"}), the defects in phagophore expansion ([Figures 7C](#F7){ref-type="fig"} and [7D](#F7){ref-type="fig"}) and autophagic degradation ([Figures 7E](#F7){ref-type="fig"} and [7F](#F7){ref-type="fig"}) in CrAtg2A/B cells were only rescued by the restoration of EGFP-Atg2A(WT) but not the EGFP-Atg2A(Δ237--431) mutant. Moreover, unlike full-length Atg2A, which restored the defective Atg9A trafficking in CrAtg2A/B cells, the accumulation of Atg9A puncta adjacent to LC3-positive foci remained upon the expression of EGFPAtg2A(Δ237--431) ([Figure S7D](#SD1){ref-type="supplementary-material"}), indicating the importance of the Atg2A-Atg9A interaction in Atg9A vesicle delivery and subsequent retrograde trafficking. Collectively, these data indicate that Atg2A recruited to the MAM by a C-terminal MLD domain interacts with Atg9A at its N terminus to regulate phagophore expansion.

DISCUSSION {#S11}
==========

It has been proposed that the phagophore forms and grows at ER-mitochondria contact sites ([@R9]), but the underlying molecular mechanisms have not been fully elucidated. In this study, we demonstrate the importance of the MAM localization of Atg2A in phagophore expansion. We found that the starvation-induced MAM localization of Atg2A is mediated through the interaction of OMM protein TOM70 and TOM40 and that Atg2A-MAM localization is required for proper Atg9A trafficking and autophagosomal membrane expansion. These results provide a mechanistic insight into phagophore growth and further support the importance of MAM in autophagosome biogenesis.

The observation that Atg2A/B depletion accumulates small immature autophagosomal membranes is consistent with previous reports ([@R40]; [@R44]). However, although these studies initially suggested a role of Atg2A/B in phagophore closure, our data show that small phagophores in CrAtg2A/B cells still can undergo membrane closure to form autophagosomes that mature into autolysosomes. Because the size of autophagic structures in CrAtg2A/B cells is much smaller than that in WT cells, we propose that the failure of membrane expansion limits efficient membrane closure to accumulate immature autophagosomal membranes. Importantly, the observations that Atg2A/B deficiency significantly reduces the lysosomal turnover of LC3-II and impairs p62 degradation are consistent with the conclusion that Atg2 is required for efficient autophagic flux. Most recently, the involvement of endosomal sorting complex required for transport-III (ESCRT-III)-mediated membrane fission in phagophore closure has been demonstrated ([@R37]). Interestingly, although the sizes of phagophores were minimally affected by the depletion of ESCRT-III CHMP2A, Atg2A accumulated on p62- and Atg9-positive immature autophagic structures in CHMP2A-depleted cells ([@R37]). As the mechanism leading to ESCRT-III recruitment to phagophores is unknown, it will be of interest to determine whether Atg2A-mediated membrane expansion is a prerequisite for efficient recruitment of the ESCRT machinery.

During autophagosome biogenesis, many ATG proteins, including ATG14, DFCP1, ATG16, Beclin1, and VPS34, translocate to the autophagosome formation sites at MAMs ([@R9]). In this study, we find that Atg2 also accumulates at MAMs during starvation. Interestingly, the MAM localization of Atg2 occurs independent of its ability to bind WIPI4, as the WIPI4 interaction-defective Atg2(YFS-AAA) mutant localizes to the MAM and rescues the defects in phagophore expansion and autophagic degradation in CrAtg2A/B cells. These results are unexpected, as yeast Atg18 has been suggested to dictate the PAS localization of Atg2 through the binding of PI3P ([@R16]; [@R26]). Instead, we find that Atg2A localizes to MAM through a 45-amino acid domain located within the previously characterized autophagosome and lipid droplet localization region at the C terminus ([@R44]). Notably, this domain is highly conserved and contains several essential arginine and leucine residues. As it is the minimal domain required for MAM localization and localizes to the MAM regardless of nutrient status, we named this the MLD.

Our proteomic analysis identifies the TOM component TOM40 as a MLD-interacting protein, and we have shown that TOM40 is responsible for the MAM localization of Atg2A through the TOM receptor TOM70. Despite restored phagophore expansion in CrAtg2A/B cells upon the artificial targeting of Atg2A(ΔMLD) to MAM by rapamycin-induced dimerization with TOM70, abnormally enlarged autophagic membranes can be observed and the defect in autophagic flux persists. As immature autophagic structures are reported to be detached from the ER in Atg2A/ B-depleted cells ([@R13]), the regulated assembly and disassembly of Atg2A-TOM40 interactions may be responsible for the establishment of phagophore-MAM contacting sites during phagophore expansion and the proper release of autophagosomes, but this remains to be studied. It also remains to be characterized how the MAM localization of Atg2 is controlled by nutrient status. Unlike full-length Atg2A, EGFPMLD strongly accumulates at MAM even under nutrient-rich culture conditions, suggesting that Atg2A may need to undergo conformational change or interact with an unknown co-factor in order to achieve MAM localization in response to autophagy induction.

During the revision of this manuscript, *in vitro* membrane tethering and lipid transfer activities have been demonstrated to reside within the N-terminal region of Atg2 ([@R25]; [@R28]; [@R43]). As mitochondria have been shown to supply lipids including PE for the biogenesis of autophagosomes ([@R8]), it is of future interest to investigate if Atg2A also mediates non-vesicular lipid transport at the MAM for phagophore expansion. Furthermore, the membrane source for the formation and/or expansion of the phagophore may also be supplied by vesicular trafficking ([@R18]). In this study, we observed that Atg2A/B deficiency accumulates Atg9A signals around LC3-positive autophagic structures. Although this observation is consistent with the notion that Atg2 regulates Atg9 retrieval from the PAS in yeast ([@R3]), we find that Atg9A vesicle-like structures are accumulated around autophagic structures at MAM in CrAtg2A/B cells to suggest that the membranes fail to be delivered to the expanding phagophore. Moreover, the Atg9-bindingdefective Atg2A(Δ237--431) mutant is capable of localizing to the MAM upon nutrient starvation but cannot restore phagophore expansion in CrAtg2A/B cells; thus, Atg2 at the MAM may function to tether or properly orient Atg9-containing vesicles for lipid delivery during phagophore expansion.

Collectively, we identify a minimal 45-amino acid MLD domain within the C terminus of Atg2A that is required for the TOM70/ TOM40-mediated translocation of Atg2A to the autophagosome formation site at the MAM for phagophore expansion. Although we show that an N-terminal domain of Atg2A supports Atg9mediated vesicular lipid transport for efficient autophagic flux, additional membrane tethering functions and/or lipid transfer activities of Atg2A at the MAM is an intriguing area for future study.

STAR⋆METHODS {#S12}
============

LEAD CONTACT AND MATERIALS AVAILABILITY {#S13}
---------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, HongGang Wang (<hwang3@pennstatehealth.psu.edu>). This study did not generate new unique reagents.

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S14}
--------------------------------------

U-2 OS (female), HeLa (female), and HEK293T (female) cells and indicated transfectants/transductants were cultured in Dulbecco's Modification of Eagle's Medium (DMEM) supplemented with 10% FBS (VWR, 97068--091) and 1 × Antibiotic-Antimycotic solution (Corning, 30--004-CI). Cells were incubated at 37°C and 5% CO~2~.

METHOD DETAILS {#S15}
--------------

### Transfection and transduction {#S16}

HEK293T cells were transfected using Calcium Phosphate method. Briefly, for 10 cm culture dish HEK293T cells, plasmid DNA (up to 15 μg) was diluted in 500 μL of 250 mM CaCl~2~ solution. 500 μL of 2 × HEPES-buffered saline (140 mM NaCl, 1.5mM Na~2~HPO~4~-2H~2~O, 50mM HEPES, pH 7.05) was added to DNA-CaCl~2~ mixture dropwise while vortex and incubated for 10 minutes at room temperature before adding to cells. Plasmid DNA and siRNA transfection in U-2 OS and HEK293T cells were performed using Nucleofector Kit V (Lonza, VCA-1003), jetPRIME (Polypus, 114--01) or FuGENE HD Transfection Reagent (Promega, E2311) per manufacturer's instructions. Lentivirus production and transduction were performed as described previously ([@R49]).

### CRISPR/Cas9 genomic editing {#S17}

CRISPR/Cas9-mediated knockout was performed as described previously ([@R40]). Briefly, sgRNAs targeting human TOM70, Atg2A, and Atg2B were sub-cloned into Lenti-sgRNA-EFS-GFP (TOM70), pLenti-CRISPR-V2 (Atg2A), and pLX-sgRNA (Atg2B) vectors, respectively. CrAtg2A/B U-2 OS, HEK293T, and HeLa cells were generated by infecting cells with pLenti-CRISPR-V2-sghAtg2A lentivirus followed by 7 days of puromycin selection. Cells were then subjected to transduction with pLXsgAtg2B lentivirus and blasticidin selection for 10 days. CrTOM70 HEK293T cells were generated by infecting cells with lentiCas9-Blast virus followed by 10 days of blasticidin selection. Cells were then subjected to transduction with Lenti-sgTOM70-EFS-GFP for 2 days and followed by GFP-positive FACS sorting. To generate Atg9A knockout cells, U-2 OS cells were transiently transfected with sgAtg9A-Cas9-P2A-GFP plasmid (Santa Cruz sc-408011) and followed by GFP-positive FACS sorting. Single clones were isolated, expanded, and screened for complete knockout by immunoblotting.

### Autophagic flux assay {#S18}

Cells were treated as described in the text prior to immunoblotting. The intensity of p62 and loading control was quantified using LI-COR Biosciences Image Studio software, and p62 levels were normalized to loading control. Basal autophagic flux (1) and starvation-induced autophagic flux (2) were calculated using the following formulas ([@R42]): (1) \[(complete media with BafA1 -- complete media)/(complete media with BafA1)\] × 100; (2) \[(starvation media with BafA1 -- starvation media)/(starvation media with BafA1)\] × 100. All data were normalized to WT.

### FACS cell death analysis {#S19}

Cells were treated as described in the text. Cells were harvested by trypsinization and washed once in PBS prior to 5% Annexin-V and 7-AAD staining for 15 mins on ice. Cells were then washed once in Annexin-V binding buffer prior to FACS analysis.

### HaloTag-LC3 autophagosome completion assay {#S20}

The assay was performed as previously described ([@R37]). Briefly, cells were incubated at 37°C with AlexaFluor488-MIL in permeabilization buffer (3 nM XF-PMP in 1 × MAS buffer (220 mM mannitol, 70 mM sucrose, 10 mM KH~2~PO~4~, 5 mM MgCl~2~, 2 mM HEPES, 1 mM EGTA)) for 15 minutes. Equal volume of 2 × fixative (8% PFA and 400 mM sucrose in 1 × PBS) was added to cells and incubated at room temperature for 7 minutes. Cells were then washed with PBS and incubated with tetramethylrhodamine (TMR)-MPL in PBS at room temperature for 30 minutes. Finally, cells were washed with PSB before confocal microscopy.

### Immunoblotting {#S21}

Cells were collected on ice by scraping and washed with ice-cold PBS and then resuspended and incubated in RIPA buffer (25 mM Tris-HCl pH 8.0, 150mM NaCl, 1mM EDTA, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, protease inhibitor cocktail) for 30 minutes on ice. Cell lysate supernatant was collected after 15 minutes 20,000 × g centrifugation. Protein concentrations were determined using BCA assay. Equal amount protein from each sample was denatured using 2 × laemmli buffer (4% SDS, 20% glycerol, 120 mM Tris- HCL pH 6.8, 0.02% bromophenol blue, 10% 2-mercaptoethanol). Samples were then heated (100°C, except 70°C for Atg9A) for 10 minutes before electrophoresis. Proteins were then transferred to PVDF membrane overnight followed by blocking and antibody incubation. Membranes were imaged using Li-Cor Odyssey CLx Infrared Imaging System.

### Co-immunoprecipitation {#S22}

Co-IP using transfected HEK293T cells was performed as described previously with minor optimization ([@R39]). For TOM40 co-IP, cells were lysed in NP-40 lysis buffer (10 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 0.5% NP-40). For Atg9A-GFP co-IP, cells were lysed in TX-100 lysis buffer (50 mM Tris-HCl pH 7.4, 75 mM NaCl, 0.8% TX-100). For Atg9A co-IP, cells were homogenized in PBS by going through 27.5-gauge needle 20 times. Triton X-100 was then added to cell homogenate (0.01% final concentration). For WIPI4 co-IP, lysis buffer recipe was obtained from previous publication ([@R50]). Cells were lysed for 30 minutes at 4°C while rotating. Cell lysates were then centrifuged for 15 minutes (20,000 × g, except 4000 × g for Atg9A) and supernatants were collected and subjected to BCA assay. 500 μg protein lysate from each sample was incubated with 25 μL post-washing GFP-Trap_MA beads for 3 hours at 4C while rotating. Beads were then washed 3 times with washing buffer (lysis buffer with 10% original detergent concentration) before immunoblotting analysis. For TOM40-Atg2A endogenous co-IP, magnetic protein-G beads (Bio-Rad, 1614021) were incubated with 10 μg TOM40 antibody (Santa Cruz) or normal mouse IgG in diluted (50% original detergent concentration) NP-40 lysis buffer for 2 hours at room temperature. Antibody-protein-G bead conjugates were washed 3 times in washing buffer prior to incubation with cell lysates (NP-40 lysis buffer) for 2 hours at room temperature. Beads were then washed 3 times with washing buffer (lysis buffer with 10% original detergent concentration) before immunoblotting analysis.

### Fluorescence microscopy {#S23}

Cells were seeded on 8-well chamber slides (Fisher Scientific, 12--565-1) overnight and subjected to indicated treatments. For TOM20 and Atg9A immunostaining, cells were fixed in 4% paraformaldehyde-PBS for 20 minutes in dark at room temperature and then subjected to 0.15% Triton X-100-PBS for 20 minutes or 100 μg/ml digitonin-PBS for 10 minutes at room temperature. Cells were rinsed with PBS 3 times and then incubated with 10% normal goat serum-PBS for 1h at room temperature before overnight incubation of indicated primary antibodies in 1% normal goat serum-PBS at 4°C. Cells were washed 3 time with PBS and then incubated with indicated secondary antibodies for 1 hour in dark at room temperature. Cells were rinsed 3 time with PBS before confocal microscopy. For endogenous LC3B immunostaining, cells were fixed in 4% paraformaldehyde-PBS briefly at room temperature (approximately 15--30 s) and then incubated with ice-cold methanol for 10 mins at −20°C. Cells were rinsed with PBS 3 times before 1.5 hours incubation with anti-LC3B antibody in 1% BSA-0.1% TWEEN-20-PBS. Cells were then rinsed with 0.1% TWEEN-20-PBS 3 times and subjected to incubation with indicated secondary antibodies and confocal microscopy. For HaloTag-LC3 MPL staining, cells were incubated with MPL in PBS for 1 hour and then washed 3 times with PBS. Leica AOBS SP8 with 63 × water-immersion lens or 63 × oil-immersion lens was used to analyze samples. Fluorescent images were then deconvolved, processed, and quantified using Huygens (Scientific Volume Imaging), IMARIS (Oxford Instruments), and Volocity (PerkinElmer) software, respectively.

### Transmission electron microscopy, immuno-gold electron microscopy, and correlative light electron microscopy {#S24}

TEM, immuno-TEM, and CLEM were performed as described previously ([@R37]). Briefly, for TEM, cells were seeded on plastic coverslip (Thermo Scientific 174950) in 24-well plate overnight. Cells were then treated with indicated conditions followed by 1 hour fixation in dark at room temperature (2% paraformaldehyde and 2.5% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.3). Samples were then incubated with osmium fixation buffer (1% osmium tetroxide with or without 1.5% potassium ferrocyanide in 0.1 M sodium cacodylate, pH 7.3) for 1 hour followed by serial ethanol dehydration and resin embedding (Electron Microscopy Sciences, 14120). 70 nm sample sections were mounted on mesh copper grids followed by uranyl acetate and lead citrate staining before analyzed using JEOL JEM 1400 transmission electron microscope. For immuno-TEM, cells were seeded on plastic coverslip in 24-well plate overnight and treated with indicated conditions followed by 2 hours fixation (4% paraformaldehyde in phosphate buffer (PB), pH 7.4) in dark at room temperature. Samples were incubated in permeabilization buffer (0.25% saponin in PB) for 30 minutes followed by 1 hour incubation with blocking buffer (10% BSA, 10% normal goat serum, 0.1% cold water fish gelatin, 0.1% saponin in PB). Samples were incubated with the primary antibody at 4°C overnight and incubated with the gold-conjugated secondary antibody at room temperature for 1 hour followed by 10 minutes fixation (1% glutaraldehyde in PB), 15 minutes washing (50 mM glycine in PBS), and signal intensification using GoldEnhance EM for 5 minutes. Samples were then processed as described above. For CLEM, cells were seeded on Gridded Glass Bottom Dish (MatTek, P35G-1/5--14-C-GRID) overnight. Cells were then treated with indicated conditions and subjected to HaloTag-LC3 autophagosome completion assay or solely MPL(TMR) staining. Samples were analyzed by confocal microscopy and cells of interest were then processed for TEM, identified by grid number.

### Photo-amino acid, UV crosslinking, and proteomic analysis {#S25}

HEK293T cells were transduced with pCDH1-tet-on-EGFP or pCDH1-tet-on-EGFP-MLD lentivirus. Cells were then selected with 2 μg/ml puromycin for 4 days. 9 × 10^6^ cells were seeded on 10 cm dish overnight and medium was replaced with 10 mL photoleucine and photo-methionine containing medium in the presence of 2 μg/ml doxycycline hyclate for 24 hours. Cells were then placed 2 cm under a 20 W 365 nm UV bench lamp (Blak-Ray XX-20BLB) and irradiated for 20 minutes. Cells were harvested and lysed on ice using NP-40 co-IP lysis buffer. Protein concentrations were determined using BCA assay. 500 μg lysate from each sample was incubated with 25 μL of post-washed GFP-Trap_MA beads for 3 hours at 4°C while rotating. Beads were then washed for 10 times and proteins were eluted with 25 μL 2 × laemmli buffer and 100°C heating for 10 minutes. Samples were then submitted for proteomic analysis at the Rutgers University Biological Mass Spectrometry Facility.

### Rapamycin-induced oligomer formation system of FRB-FKBP fusion proteins {#S26}

U-2 OS cells were transduced with lentivirus encoding FRB-EGFP-Atg2A(ΔMLD) followed by TOM20-mRFP-FKBP or TOM70-smRFP-FKBP prior to EGFP and mRFP double positive FACS sorting. Cells were treated with DMSO or 150 nM rapamycin for 8 hours prior to immunostaining and confocal microscopy.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S27}
---------------------------------------

Fluorescence microscopy quantifications were performed using Velocity and IMARIS software. Immunoblotting quantifications were performed using Image Studio software.

Statistical significance was determined using Graph Pad Prism 7.0. Statistical computation, threshold for significance, and *n* numbers were indicated on each figure.

DATA AND CODE AVAILABILITY {#S28}
--------------------------

Original proteomics data for [Figure 5A](#F5){ref-type="fig"} and [Table S1](#SD1){ref-type="supplementary-material"} in the paper is available at Mendeley Data <https://doi.org/10.17632/tn4p7g48hm.2>.
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![Atg2A/B Is Required for Autophagosomal Membrane Expansion\
(A) HaloTag-LC3 (HT-LC3)-expressing wild-type (WT) and Atg2A/B double knockout (CrAtg2A/B) U-2 OS cells were incubated in complete media (CM) or starvation media (SM) in the presence or absence of 100 nM Baf-A1 for 2 h and subjected to the HT-LC3 autophagosome completion assay followed by confocal microscopy. Magnified images of the boxed (i--iii) and arrow-indicated areas (a--j) are shown in the middle and right panels, respectively. Schematic illustration of phagophore (MIL^+^MPL^−^), nascent autophagosome (MIL^+^MPL^+^), and mature autophagosome (MIL^−^MPL^+^) are shown on the upper right panel. Scale bars represent 20 μm and 1 μm in the magnified images.\
(B and C) The cytoplasmic fluorescence intensities of MIL (B) and MPL (C) in each cell under indicated conditions were quantified and normalized to the respective mean fluorescence intensities of WT cells starved in the presence of Baf-A1 (n = 50).\
(D) MIL/MPL ratio for each cell incubated in CM or SM in the presence of Baf-A1 was calculated and normalized to the mean of fluorescence intensities of WT cells (n = 50).\
(E) The diameters of HT-LC3 foci randomly selected from the starved WT and CrAtg2A/B were quantified using the Velocity software (n = 100).\
(F) WT and CrAtg2A/B U-2 OS cells were starved for 2 h and subjected for TEM. Representative autophagosome-like and autolysosome-like structures are shown on the upper and lower panels, respectively. Scale bars represent 200 nm.\
(G) The diameter of each autophagic structure randomly selected from the electron micrographs was quantified (n = 20).\
(H) HT-LC3-expressing CrAtg2A/B U-2 OS cells were starved for 2 h, stained for with MIL and MPL, and subjected to CLEM. Magnified images of the boxed areas are shown on the right panels.\
Arrows and arrowheads indicate autophagosome-like and autolysosome-like structures, respectively. Scale bars represent 10 μm and 1 μm in the magnified image. Statistical significance was determined by one-way ANOVA followed by Dunn's multiple comparisons test (B and C) or t test (D, E, and G). All values are mean ± SD; n.s., not significant; \*p ≤ 0.05; ^\*\*^p ≤ 0.01; ^\*\*\*^p ≤ 0.001; ^\*\*\*\*^p ≤ 0.0001.](nihms-1537433-f0002){#F1}

![Atg2A Localizes to MAM upon Autophagy Induction\
(A) CrAtg2A/B U-2 OS cells were transduced with lentiviruses encoding sgRNA-resistant EGFP-Atg2A, starved for 2 h and subjected to immunoelectron microscopy using anti-GFP antibody. Scale bars represent 200 nm.\
(B) EGFP-Atg2A- and dsRed-ER-expressing CrAtg2A/B U-2 OS cells were incubated in CM or SM for 2 h, stained for TOM20, and analyzed by confocal microscopy. Magnified images of the boxed areas are shown in the lower panels. Scale bars represent 10 μm and 2.5 μm in the magnified images.\
(C) The fluorescence intensity of EGFP-Atg2A in each cell under indicated conditions was quantified and normalized to the respective mean fluorescence intensity of cells incubated in CM (n = 40).\
(D and E) Total EGFP-Atg2A puncta number per cell (D) and the percentage of EGFP-Atg2A puncta localize to cytosol (ER^−^MITO^−^), ER (ER^+^MITO^−^), mitochondria (ER^−^MITO^−^), or MAM (ER^+^MITO^+^) under CM or SM were quantified (n = 30) (E).\
Statistical significance was determined by t test (C and D) or one-way ANOVA followed by Dunn's multiple comparisons test (E). All values are mean ± SD. \*p ≤ 0.05; ^\*\*\*\*^p ≤ 0.0001.](nihms-1537433-f0003){#F2}

![The MLD of Atg2A Is Responsible for the Interaction with TOM40\
(A) Schematic illustration of EGFP-Atg2A variants.\
(B--D, G, and H) CrAtg2A/B HEK293T cells were transfected with the indicated EGFP-Atg2A variants for 24 h and subjected to immunoprecipitation with GFPTrap beads followed by immunoblotting with the indicated antibodies. EV and WCL represent EGFP-empty vector and whole-cell lysate, respectively.\
(E) Amino acid sequences of the MLD and its variants used in the study are shown. Red underlined characters indicate the point mutations introduced into the sequences.\
(F) Helical wheels of N-terminal (left) and C-terminal (right) α helices of MLD were plotted using HeliQuest. Red asterisks indicate amino acid residues substituted to alanine.](nihms-1537433-f0004){#F3}

![MAM Localization of Atg2A Is Required for Its Biological Function in Autophagy\
(A) CrAtg2A/B U-2 OS cells stably expressing the indicated EGFP-Atg2A variants and dsRed-ER were starved for 2 h, stained for TOM20, and analyzed by confocal microscopy. Magnified images in the boxed areas are shown in the lower panels. Scale bars represent 20 μm and 5 μm in the magnified images.\
(B) The fluorescence intensity in each cell expressing the indicated Atg2A variant was quantified and normalized to the respective mean fluorescence intensity of EGFP-Atg2A(WT) cells (n = 38).\
(C and D) U-2 OS cells expressing the indicated EGFP-Atg2A variants were starved for 2 h, stained for LC3, and analyzed by confocal microscopy. In (C), LC3 is pseudo-colored green for visualization, and magnified images in the boxed areas are shown in the insets. Scale bars represent 20 μm and 5 μm in the insets. EV represents EGFP-empty vector. In (D), the diameters of LC3 foci were randomly selected and quantified using the Velocity software (n = 50).\
(E--J) The indicated U-2 OS stable transductants were incubated in CM or SM for 2 h in the presence or absence of 100 nM Baf-A1 and subjected to immunoblotting with the indicated antibodies (E, G, and I). Basal and starvation-induced autophagic flux was quantified (F, H, and J; n = 3) as described in the [STAR Methods](#S12){ref-type="sec"}. Statistical significance was determined by one-way ANOVA followed by Dunn's multiple comparisons test. All values are mean ± SD; n.s., not significant; \*p ≤ 0.05; ^\*\*^p ≤ 0.01; ^\*\*\*^p ≤ 0.001; ^\*\*\*\*^p ≤ 0.0001.](nihms-1537433-f0005){#F4}

![TOM70 Mediates the Atg2A-TOM40 Interaction and Atg2A-Dependent Phagophore Growth\
(A) TOM components and their corresponding peptide numbers identified in the proteomic analysis using EGFP-MLD are listed.\
(B) HEK293T cells were transduced with lentiviruses encoding Cas9 and sgRNAs targeting TOM70 (CrTOM70) and subjected to immunoblotting with the indicated antibodies.\
(C) WT or CrTOM70 HEK293T cells were transfected with the EGFP (EV) or EGFP-Atg2A (Atg2A) for 24 h and subjected to immunoprecipitation with GFP-Trap beads followed by immunoblotting with the indicated antibodies.\
(D--F) The indicated CrAtg2A/B U-2 OS stable transductants were treated with DMSO or 150 nM rapamycin in the presence or absence of 100 nM Bafilomycin A1 for 8 h and subjected to LC3 immunostaining and confocal microscopy (D) or immunoblotting with the indicated antibodies (F). In (E), the diameters of LC3 foci in (D) were randomly selected and quantified using the Velocity software (n = 60).\
Statistical significance was determined by one-way ANOVA followed by Dunn's multiple comparisons test. All values are mean ± SD; n.s., not significant; \*\*\*\*p ≤ 0.0001.](nihms-1537433-f0006){#F5}

![Atg2A/B Deficiency Accumulates Atg9 Vesicles at the Autophagosome Formation Sites in the Close Proximity of the MAM\
(A) GFP- or Atg9A-GFP-expressing CrAtg2A/B HEK293T cells were transfected with myc-Atg2A for 24 h and subjected to immunoprecipitation with GFP-Trap beads followed by immunoblotting with the indicated antibodies.\
(B) WT and CrAtg9A U-2 OS cells were incubated in CM or SM in the presence or absence of 100 nM Baf-A1 and subjected to immunoblotting with the indicated antibodies.\
(C) The indicated U-2 OS cells were starved for 2 h, stained for LC3, and analyzed by confocal microscopy. Magnified images in the boxed areas are shown in the insets. Scale bars represent 20 μm and 5 μm in the magnified images.\
(D) The diameters of LC3 foci were randomly selected and quantified using the Velocity software (n = 100).\
(E) HT-LC3-expressing WT and CrAtg2A/B U-2 OS cells were starved for 2 h, stained for Atg9A and MPL (TMR), and analyzed by confocal microscopy. Magnified images of the boxed areas are shown in the right panels (i and ii) and insets (iii). Scale bars represent 20 μm, 2 μm in the magnified images, and 0.5 μm in the insets.\
(F) Colocalization coefficient of HT-LC3 with Atg9A per cell was quantified using the Velocity software and shown (n = 40).\
(G) CrAtg2A/B U-2 OS cells stably expressing HT-LC3 and Atg9A-GFP were starved for 2 h, stained for MPL (TMR), and subjected to CLEM. Scale bars represent 10 μm and 0.5 μm in the magnified images. Magnified images of the boxed areas are shown in the middle (i) and right panels (a and b). Red and blue arrowheads indicate Atg9A-GFP-positive vesicles and HT-LC3-positive autophagic structures, respectively.](nihms-1537433-f0007){#F6}

![The Interaction of Atg2A with Atg9 Is Indispensable for Phagophore Expansion\
(A) Schematic diagrams of EGFP-tagged WT and Atg9A binding-defective Atg2A variant.\
(B) GFP- or Atg9A-GFP-expressing CrAtg2A/B HEK293T cells were transfected with myc-Atg2A variants for 24 h and subjected to immunoprecipitation with GFP-Trap beads followed by immunoblotting with the indicated antibodies.\
(C) U-2 OS cells expressing the indicated EGFP-Atg2A variants were starved for 2 h, stained for LC3, and analyzed by confocal microscopy. LC3 is pseudocolored green for visualization, and magnified images in the boxed areas are shown in the insets. Scale bars represent 20 μm and 5 μm in the magnified images. EV represents EGFP-empty vector.\
(D) The diameters of LC3 foci were randomly selected and quantified using the Velocity software (n = 120). EV, WT, and Δ represent EGFP-empty vector, EGFP-Atg2A(WT), and EGFP-Atg2A(Δ237--431), respectively.\
(E and F) The indicated U-2 OS cells were incubated in CM or SM for 2 h in the presence or absence of 100 nM Baf-A1 and subjected to immunoblotting with the indicated antibodies (E). Basal and starvation-induced autophagic flux in the indicated U-2 OS stable transductants were quantified as described in the [STAR Methods](#S12){ref-type="sec"} (n = 3) (F).\
Statistical significance was determined by one-way ANOVA followed by Dunn's multiple comparisons test. All values are mean ± SD; n.s., not significant; \*\*p ≤ 0.01; \*\*\*\*p ≤ 0.0001.](nihms-1537433-f0008){#F7}

  REAGENT or RESOURCE                                          SOURCE                         IDENTIFIER
  ------------------------------------------------------------ ------------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Antibodies                                                                                  
  rabbit polyclonal anti-Atg2A                                 MBL International              Cat\# PD041; RRID: AB_2810871
  rabbit polyclonal anti-Atg2B                                 Proteintech Group              Cat\# 25155--1-AP; RRID: AB_2810874
  rabbit monoclonal anti-Atg9A                                 Cell Signaling Technology      Cat\# 13509; RRID: AB_2798241
  mouse monoclonal anti-α-tubulin                              Sigma-Aldrich                  Cat\# T5168; RRID: AB_477579
  mouse monoclonal β-actin                                     Sigma-Aldrich                  Cat\# A5441; RRID: AB_476744
  rabbit polyclonal anti-GFP                                   Abcam                          Cat\# ab6556; RRID: AB_305564
  mouse monoclonal anti-GST                                    Santa Cruz Biotechnology       Cat\# sc-138; RRID: AB_627677
  rabbit monoclonal anti-HSP90                                 Cell Signaling Technology      Cat\# 4877; RRID: AB_2233307
  rabbit monoclonal anti-LC3B                                  Cell Signaling Technology      Cat\# 3868; RRID: AB_2137707
  rabbit monoclonal anti-Atg13                                 Cell Signaling Technology      Cat\# 13273; RRID: AB_2798169
  rabbit polyclonal anti-LC3                                   Novus Biologicals              Cat\# NB100--2220; RRID: AB_10003146
  mouse monoclonal anti-mCherry                                Abcam                          Cat\# ab125096; RRID: AB_11133266
  mouse monoclonal anti-Myc-Tag                                Cell Signaling Technology      Cat\# 2276; RRID: AB_331783
  normal mouse IgG                                             Santa Cruz Biotechnology       Cat\# sc-2025; RRID: AB_737182
  mouse monoclonal anti-TOM70                                  Santa Cruz Biotechnology       Cat\# sc-390545; RRID: AB_2714192
  guinea pig polyclonal anti-p62                               American Research Product      Cat\# 03-GP62-C; RRID: AB_1542690
  mouse monoclonal anti-TOM20                                  Santa Cruz Biotechnology       Cat\# sc-17764; RRID: AB_628381
  mouse monoclonal anti-TOM40                                  Santa Cruz Biotechnology       Cat\# sc-365467; RRID: AB_10847086
  donkey anti-rabbit IgG IRDye 800CW                           LiCOr                          Cat\# 925--32213; RRID: AB_2715510
  donkey anti-rabbit IgG IRDye 680RD                           LiCOr                          Cat\# 925--68073; RRID: AB_2716687
  donkey anti-mouse IgG IRDye 800CW                            LiCOr                          Cat\# 925--32212; RRID: AB_2716622
  donkey anti-mouse IgG IRDye 680RD                            LiCOr                          Cat\# 925--68072; RRID: AB_10953628
  donkey anti-guinea pig IgG IRDye 680RD                       LiCOr                          Cat\# 925--68077; RRID: AB_10956079
  Nanogold-Fab goat anti-rabbit IgG                            Nanoprobes                     Cat\# 2004; RRID: AB_2631182
  goat anti-rabbit IgG Alexa Fluor 488                         Life Technologies              Cat\# A-11008; RRID: AB_143165
  goat anti-rabbit IgG Alexa Fluor 568                         Life Technologies              Cat\# A-11031; RRID: AB_144696
  goat anti-mouse IgG Alexa Fluor 647                          Life Technologies              Cat\# A-21238; RRID: AB_2535807
  GFP-Trap                                                     ChromoTek                      Cat\# gtma-20; RRID: AB_2631406
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###### Highlights

-   Human Atg2 functions at the phagophore expansion step

-   Atg2A translocates to MAM during autophagy

-   TOM40/70 complex recruits Atg2A to MAM

-   Atg2A regulates Atg9-vesicle delivery for phagophore expansion at MAM
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